Scott Hensley -NPR
Food prices are no longer rising as much — but here’s why it might not feel that way
Food prices have largely leveled off, but many people are still frustrated when they go to their local grocery store.
The FDA postpones a highly anticipated meeting on the Pfizer vaccine for young kids
"We believe additional information regarding the ongoing evaluation of a third dose should be considered as part of our decision-making for potential authorization," FDA officials said in a statement.
CDC backs expansion of COVID boosters for all adults
CDC Director Rochelle Walensky gave the green light to boosters just hours after a panel of vaccine advisors voted unanimously to recommend boosters for anyone 18 and older.
Pfizer-BioNTech COVID vaccine appears more than 90% effective in kids 5 to 11
The companies studied a 10 microgram vaccine dose in children 5 to 11, a third of the dose used for adults, to minimize side effects and because it still prompts a strong immune response.
CDC advisers back rollout of COVID vaccine boosters from Moderna and J&J
A panel advising the Centers for Disease Control and Prevention also endorsed a mix-and-match approach to boosters that would be flexible for patients and health care providers.
The FDA authorizes Moderna and J&J COVID vaccine boosters
The Food and Drug Administration also gave an OK to boosters that differ from the vaccine originally used to immunize people against COVID-19. A mix-and-match approach could ease the booster rollout.
Moderna and J&J say their data supports COVID vaccine boosters
The Food and Drug Administration released briefing documents Tuesday on booster shots for the Moderna and Johnson & Johnson COVID vaccines ahead of a two-day advisory meeting that starts Thursday.
The FDA OKs Pfizer-BioNTech booster for people 65+ and at high risk for severe COVID
A third shot of the vaccine can be given at least six months after the two-dose regimen, according to the authorization. A booster rollout could begin this week.
Pfizer’s COVID vaccine gets full approval from the FDA
The Food and Drug Administration has formally approved Pfizer's COVID-19 vaccine. The widely anticipated decision replaces the emergency use authorization granted by the agency last December.